Double balloon catheter and methods for homogeneous drug delivery using the same

• US 8,162,879 B2
• Filed: 09/22/2009
• Issued: 04/24/2012
• Est. Priority Date: 09/22/2008
• Status: Active Grant

• Current Assignee: Covidien LP (Medtronic Plc)
• Original Assignee: Tyco Healthcare Group LP (Medtronic Plc)
• Inventors: Hattangadi, Neil, Lerner, Daniel, Olivera, Ryan
• Primary Examiner(s): Mehta, Bhisma
• Application Number:
  US12/564,771
• Publication Number:
  US 20100082012A1
• Time in Patent Office: 945 Days
• Field of Search: 604/96.01, 604/100.01, 604/101.01, 604/101.03, 604/101.04, 604/101.05, 604/102.01, 604/102.02, 604/102.03, 604/103.1
• US Class Current: 604/101.03
• CPC Class Codes: A61L 2300/416 Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
• CPC Class Codes: A61L 2300/602 Type of release, e.g. controlled, sustained, slow
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61M 2025/1052 for temporarily occluding a vessel for isolating a sector
• CPC Class Codes: A61M 25/007 Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
• CPC Class Codes: A61M 25/1011 Multiple balloon catheters

Abstract

The invention, in one embodiment, is directed to a catheter for site-specific delivery of a therapeutic agent to a blood vessel of a patient. The catheter further includes an elongated shaft having at least one inner lumen, a distal end and a proximal end and proximal and distal vessel-conforming balloons where each is separately positionable and inflatable, and when inflated, substantially restricts blood flow in the vessel and creates a treatment window of a defined but variable length for delivery of the therapeutic agent. The catheter optionally includes at least one marker band adjacent to the proximal balloon and at least one marker band adjacent to the distal balloon. At least one lateral aperture positioned in the window is in fluid communication with a drug delivery conduit located within either the inner shaft or the outer shaft to provide a homogeneous concentration of the therapeutic agent to the window.

Claims

1. A catheter system for site-specific delivery of a therapeutic agent to a blood vessel of a patient comprising:

a. an elongated shaft assembly having an inner shaft, an outer shaft, a distal end, and a proximal end;

b. proximal and distal vessel-conforming balloons, each of the proximal and distal balloons being separately positionable and inflatable to restrict blood flow in the vessel, the proximal and distal balloons defining a treatment window of a defined but variable length for delivery of the therapeutic agent;

c. at least one marker band adjacent to the proximal balloon and at least one marker band adjacent to the distal balloon;

d. the outer shaft defining a drug delivery lumen and at least one delivery aperture, the drug delivery lumen and the at least one delivery aperture being in fluid communication to deliver the therapeutic agent to the treatment window;

e. the inner shaft defining a distal opening, a drug passing lumen, and at least one distal leak aperture;

the distal opening, the drug passing lumen, and the at least one distal leak aperture being in fluid communication to form a distal leak path;

the at least one distal leak aperture being disposed in the treatment window to allow fluid within the treatment window to exit the treatment window through the distal leak path as the therapeutic agent is delivered to the treatment window through the drug delivery lumen so as to provide a homogeneous concentration of the therapeutic agent to the treatment window; and

f. a guidewire configured to block the at least one distal leak aperture and being movably positioned within the elongated shaft assembly between first and second positions such that movement of the guidewire to one of the first and second positions closes the at least one distal leak aperture to isolate the therapeutic agent within the treatment window and movement of the guidewire to the other of the first and second positions exposes the at least one distal leak aperture to permit the fluid disposed in treatment window to pass from the treatment window.

2. The catheter system of claim 1, wherein the balloons are inflatable at a pressure so as to substantially limit barotrauma to the blood vessel.

3. The catheter system of claim 2, wherein the vessel-conforming balloons are inflated at a pressure of less than about 15 psi in the vessel.

4. The catheter system of claim 1, wherein the vessel-conforming balloons inhibit the flow of blood through the vessel.

5. The catheter system of claim 1, wherein one of the at least one marker bands is positioned immediately adjacent to at least one of the balloons.

6. The catheter system of claim 1, wherein the at least one marker band adjacent to the proximal balloon is located proximal to the proximal balloon and the at least one marker band adjacent to the distal balloon is located distal to the distal balloon.

7. The catheter system of claim 1, wherein the at least one marker band adjacent to the proximal balloon is located distal to the proximal balloon and the at least one marker band adjacent to the distal balloon is located proximal to the distal balloon.

8. The catheter system of claim 1, further comprising a balloon inflation port for the distal balloon and a balloon inflation port for the proximal balloon.

9. The catheter system of claim 1, further comprising a drug infusion port in fluid connection with the drug delivery lumen.

10. The catheter system of claim 1, wherein the length of the treatment window is variable.

11. The catheter system of claim 10, wherein the length of the treatment window is from 2 centimeters to 25 centimeters.

12. The catheter system of claim 11, wherein the length of the treatment window is from 3 centimeters to 10 centimeters.

13. The catheter system of claim 1, wherein the number of delivery apertures is from 2 to 20.

14. The catheter system of claim 13, wherein the number of delivery apertures is 4, 8 or 16.

15. The catheter system of claim 13, wherein the delivery apertures are in a plane and placed at an angle of about 90 to about 180 degrees apart.

16. The catheter system of claim 13, wherein the delivery apertures are helically positioned at an angle of about 90 to about 180 degrees apart.

17. The catheter system of claim 13, wherein the distance between the delivery apertures is about 1 to about 5 cm.

18. The catheter system of claim 13, wherein the distance between the delivery apertures is about 2.8 cm.

19. The catheter system of claim 13, wherein the diameter of the delivery apertures is from about 0.001 inches to about 0.050 inches.

20. The catheter system of claim 19, wherein the diameter of the delivery apertures is from about 0.001 inches to about 0.018 inches.

21. A catheter system for site-specific delivery of a therapeutic agent to a blood vessel of a patient comprising:

an elongated shaft assembly having an inner shaft and an outer shaft,

the outer shaft defining at least one delivery aperture and an outer shaft lumen that are in fluid communication with one another,

the inner shaft defining at least one leak aperture, an inner shaft lumen, and a distal opening that are in fluid communication with one another,

wherein the at least one leak aperture of the inner shaft is positioned distal of the at least one delivery aperture of the outer shaft;

a proximal balloon and a distal balloon supported on the outer shaft and the inner shaft, respectively, of the elongated shaft assembly, a treatment window being defined between the proximal and distal balloons when the proximal and distal balloons are inflated to maintain a therapeutic agent delivered through the outer lumen and the at least one delivery aperture between the balloons for treating a vessel of a patient; and

a guidewire movably positioned with the inner lumen of the inner shaft from a first position spaced from the at least one leak aperture to a second position blocking the at least one leak aperture, wherein the guidewire maintains the therapeutic agent within the treatment window in the second position, and wherein the at least one leak aperture permits fluid disposed in the treatment window to escape the treatment window when the therapeutic agent is delivered into the treatment window when the guidewire is in the first position such that the fluid disposed in the treatment window passes through the at least one leak aperture and the inner lumen of the inner shaft and out the distal opening of the inner shaft.

22. The catheter system of claim 21, further comprising at least one marker band adjacent at least one of the proximal balloon and the distal balloon.

23. The catheter system of claim 21, wherein at least one of the inner and outer shaft is movable relative to the other of the inner and the outer shaft to change the length of the treatment window.

24. A method for site-specific delivery of a therapeutic agent to a blood vessel of a patient comprising the steps of:

providing the catheter system of claim 21;

delivering the therapeutic agent to the treatment window through the outer lumen and at least one delivery aperture;

positioning the guidewire adjacent the at least one leak path to maintain the therapeutic agent within the treatment window; and

moving the guidewire so that the fluid disposed in the treatment window can escape through the at least one leak path and pass through the distal opening of the inner shaft when the therapeutic agent is delivered to the treatment window.

25. The method of claim 24, further comprising the step of varying the length of the treatment window.